HSBC MF reports India’s economy may have bottomed out, with growth expected to pick up due to supportive rates, crude prices, ...
The market might be buoyant right now, making it easy to focus on short-term gains. However, the property cycle is inevitable ...
With equities among the most expensive in history, the biggest rotation in your lifetime is unfolding that’ll likely trigger ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min College Hill's nonprofit ...
The U.S. Supreme Court’s landmark decision in South Dakota v. Wayfair, Inc. (138 S. Ct. 2080, 2018) overturned years of precedent that had precluded states from imposing sales taxes on sellers who ...
In the initial half of 2023, central banks globally reached the climax of their interest rate hike cycles, a move necessitated by spiraling inflation. This decision dealt a significant blow to the ...
Discover Bloomberg Economics' latest analysis on key issues, including the significance of downward job revisions and the ...
Artificial light weakens menstrual cycle's natural synchronization with lunar phases, study suggests
There is no question that the moon has a significant influence on Earth. Its gravitational pull affects the planet and moves water masses in the daily rhythm of ebb and flow (tides)—this point is ...
Athens University of Economics and Business in Greece. Credit: Wikimedia Commons / C Messier / CC BY SA 4.0 Greece’s Athens University of Economics and Business (AUEB) has once again secured ...
Abstract: Nowadays, dual active bridge (DAB) converters are widely used due to the advantages of wide voltage regulation range, high efficiency, and easy realization of soft switching. In order to ...
CELINA, Texas — This article was originally published by our content partners at the Dallas Business Journal. You can read the original article here. A project that's transforming historic downtown ...
GLEN ALLEN, Va., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results